Study of clinical and laboratory profile of patients with reactive arthritis in a tertiary healthcare center
DOI:
https://doi.org/10.3126/ajms.v13i8.43658Keywords:
Sacroiliitis; Spondyloarthropathy; SynovitisAbstract
Background: Reactive arthritis (ReA) is a spondyloarthropathic disorder characterized by joint pain and swelling triggered by an infection in another part of the body – most often the intestines, genitals, or urinary tract. This condition usually targets the knees, ankles, and feet. The present study was conducted to study the clinical, microbiological, and laboratory profile of patients with ReA and to determine the outcomes over a duration of 3 months.
Aims and Objectives: This study aimed to assess the clinical and laboratory profile of patients with ReA in a tertiary healthcare center.
Materials and Methods: This was a prospective analytical study undertaken in the Rheumatology Out Patient Department of a tertiary care center. The study involved 73 participants and was completed over a duration of 18 months.
Results: Majority of the subjects belonged to the age group of 18–25 years (54.79%), followed by 26–35 years (23.29%) and 36–45 years (10.96%). The mean age of the study subjects was 28.71 ± 10.72 years (median age –25 years). Most of the patients were male (82.19%). While majority of the subjects showed improvement with Non Steroidal Anti-inflammatory Drugs (NSAIDs) (80.82%), steroids were used among 12.33% subjects, sulfasalazine was used among 15.07%, and methotrexate among 1.37% of the study subjects.
Conclusion: Statistically significant association was found between HLA B27 positivity and DAREA score, presence of sacroiliitis and extra-articular manifestation. NSAIDs remain the first line agents for patients with ReA. However, high baseline DAREA and ESR of more than 30 is associated with poor response to NSAIDs.
Downloads
180
107
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
